Free Trial

TELA Bio (TELA) Competitors

TELA Bio logo
$2.01 +0.01 (+0.50%)
Closing price 04:00 PM Eastern
Extended Trading
$2.01 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TELA vs. NNOX, SKIN, ZIMV, BSGM, SNWV, DRTS, NYXH, SMTI, CATX, and BWAY

Should you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Nano-X Imaging (NNOX), Beauty Health (SKIN), ZimVie (ZIMV), Biosig Technologies (BSGM), Sanuwave Health (SNWV), Alpha Tau Medical (DRTS), Nyxoah (NYXH), Sanara MedTech (SMTI), Perspective Therapeutics (CATX), and Brainsway (BWAY). These companies are all part of the "medical equipment" industry.

TELA Bio vs. Its Competitors

Nano-X Imaging (NASDAQ:NNOX) and TELA Bio (NASDAQ:TELA) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

In the previous week, Nano-X Imaging and Nano-X Imaging both had 1 articles in the media. Nano-X Imaging's average media sentiment score of 1.89 beat TELA Bio's score of 1.28 indicating that Nano-X Imaging is being referred to more favorably in the media.

Company Overall Sentiment
Nano-X Imaging Very Positive
TELA Bio Positive

Nano-X Imaging currently has a consensus target price of $9.50, indicating a potential upside of 93.48%. TELA Bio has a consensus target price of $7.25, indicating a potential upside of 260.70%. Given TELA Bio's higher probable upside, analysts clearly believe TELA Bio is more favorable than Nano-X Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nano-X Imaging
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
TELA Bio
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

TELA Bio has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nano-X Imaging$11.28M25.15-$53.52M-$0.90-5.46
TELA Bio$69.30M1.15-$37.84M-$1.41-1.43

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 94.4% of TELA Bio shares are owned by institutional investors. 4.7% of TELA Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

TELA Bio has a net margin of -61.00% compared to Nano-X Imaging's net margin of -472.19%. Nano-X Imaging's return on equity of -30.92% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Nano-X Imaging-472.19% -30.92% -27.73%
TELA Bio -61.00%-402.45%-62.73%

Nano-X Imaging has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500.

Summary

Nano-X Imaging and TELA Bio tied by winning 7 of the 14 factors compared between the two stocks.

Get TELA Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TELA vs. The Competition

MetricTELA BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$79.52M$2.90B$5.53B$9.30B
Dividend YieldN/A2.43%4.59%4.02%
P/E Ratio-1.4320.2228.5619.60
Price / Sales1.15187.07361.1874.21
Price / CashN/A41.0524.7327.56
Price / Book2.797.618.155.55
Net Income-$37.84M-$55.11M$3.24B$257.73M
7 Day Performance2.55%7.56%2.03%0.95%
1 Month Performance18.24%11.47%8.29%10.68%
1 Year Performance-57.23%0.88%28.40%15.67%

TELA Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TELA
TELA Bio
2.8886 of 5 stars
$2.01
+0.5%
$7.25
+260.7%
-60.3%$79.52M$69.30M-1.43120Positive News
NNOX
Nano-X Imaging
2.136 of 5 stars
$5.12
-3.8%
$9.50
+85.5%
-42.2%$307.38M$11.28M-5.69190Positive News
SKIN
Beauty Health
0.2905 of 5 stars
$2.20
-3.5%
$1.42
-35.6%
-7.0%$287.27M$334.30M-5.371,030
ZIMV
ZimVie
2.016 of 5 stars
$9.43
-8.0%
$16.33
+73.2%
-52.2%$285.43M$449.75M-13.281,770
BSGM
Biosig Technologies
1.9194 of 5 stars
$11.55
+11.0%
$10.00
-13.4%
+1,200.0%$284.14M$40K0.0050News Coverage
Gap Up
High Trading Volume
SNWV
Sanuwave Health
N/A$33.17
+4.8%
N/AN/A$270.79M$36.19M-7.2840
DRTS
Alpha Tau Medical
3.1409 of 5 stars
$3.29
+3.8%
$8.00
+143.2%
+45.2%$268.88MN/A-7.1580Gap Up
NYXH
Nyxoah
2.5259 of 5 stars
$7.86
+1.2%
$14.50
+84.5%
-16.9%$264.65M$4.89M-3.69110Positive News
SMTI
Sanara MedTech
2.357 of 5 stars
$29.17
-1.6%
$49.50
+69.7%
0.0%$263.52M$86.67M-21.7760News Coverage
High Trading Volume
CATX
Perspective Therapeutics
2.2266 of 5 stars
$3.48
-5.4%
$12.56
+260.8%
-69.0%$258.31MN/A0.0070News Coverage
Positive News
Analyst Upgrade
Gap Up
BWAY
Brainsway
2.6648 of 5 stars
$13.37
+1.0%
$14.25
+6.6%
+86.4%$250.17M$41.02M66.85120Gap Up

Related Companies and Tools


This page (NASDAQ:TELA) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners